FGF21 and obesity due to melanocortin 4 receptor deficiency: Treatment with FGF21 corrects metabolic disorders such as hyperglycemia, hyperlipidemia and insulin resistance in rodent and primate models of diabetes and obesity [27], [28], [29], [30].